| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 26, 2010Medtronic CoreValve(R) System Shows Long-Term Efficacy and Durability in Pivotal Trial
PARIS, May 26, 2010 (BUSINESS WIRE) --New clinical data presented today at EuroPCR demonstrate positive long-term performance and durability for the CoreValve transcatheter aortic valve...
-
May 25, 2010International Revenue Growth of 20 Percent
MINNEAPOLIS, May 25, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT): First $4 Billion Sales Quarter in Company History Full Year Revenue of $15.8 Billion Increased 8 Percent Full Year Non-GAAP...
-
May 25, 2010Data Demonstrates That Revolutionary Treatment for Patients with Diseased Heart Valves Is Transitioning Successfully into Standard Clinical Practice throughout Europe
PARIS, May 25, 2010 (BUSINESS WIRE) --New European data from five national clinical registries presented today at EuroPCR report positive clinical outcomes for one of the most exciting emerging...
-
May 25, 2010One-Year Clinical Results from Innovative RESOLUTE All Comers Trial Show Excellent Performance for Resolute DES in Challenging Patient Population
PARIS, May 25, 2010 (BUSINESS WIRE) --The highly anticipated first results of the RESOLUTE All Comers study were presented today during the late-breaking clinical trial session of the 2010 EuroPCR...
-
May 20, 2010Medtronic Institutional Investor and Analyst Meeting Scheduled for Monday, June 7, 2010, 10 a.m. - 2:30 p.m. Eastern
MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Monday, June 7, 2010, in New York City from 10 a.m. - 2:30 p.m. Eastern...
-
May 20, 2010Cardiology Meeting in Paris May 25-28 Includes New Data on Resolute(R) Drug-Eluting Stent, IN.PACT Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve
MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), announced today the schedule of important clinical data presentations during EuroPCR, a major cardiology meeting taking...
-
May 19, 2010Minimally-Invasive Procedure May Stabilize Aortic Bleeding When Surgery Is Not an Option
MINNEAPOLIS, May 19, 2010 (BUSINESS WIRE) --Further demonstrating its commitment to proving the benefits of minimally-invasive procedures, Medtronic, Inc. (NYSE: MDT), today announced that the...
-
May 17, 2010
MINNEAPOLIS, May 17, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), today announced it will participate in the 2010 Citi Investment Research Global Health Care Conference on Wednesday, May...
-
May 15, 2010Studies Presented at Heart Rhythm 2010 Demonstrate Advantages of Advanced Shock Reduction Technologies
MINNEAPOLIS & DENVER, May 15, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new data from the MVP (Managed Ventricular Pacing) trial that implantable defibrillator patients...
-
May 14, 2010Shareholders Invited to Attend Annual Meeting on Aug. 25, 2010
MINNEAPOLIS & DENVER, May 14, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial data showing the...
-
May 14, 2010Trial Demonstrates Significant Decrease in Symptoms and Improved Quality of Life for AF Patients Treated with Arctic Front(R) Cardiac CryoAblation Catheter
MINNEAPOLIS & DENVER, May 14, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial data showing the...
-
May 13, 2010New Medtronic Evidence on Shock Reduction Device Programming Strategies Released At Heart Rhythm 2010
MINNEAPOLIS & DENVER, May 13, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new evidence demonstrating that key shock-reduction programming strategies significantly reduced...
-
May 13, 2010Results of Virtual ICD Study Presented at Heart Rhythm 2010
MINNEAPOLIS & DENVER, May 13, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) released the Virtual ICD study data today that predicted 98 percent of studied implantable defibrillator patients...
-
May 12, 2010Webcast Scheduled for 7 a.m. CDT, May 25, 2010
MINNEAPOLIS, May 12, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for its fourth quarter and fiscal year on Tuesday, May 25, 2010. A news...
-
May 10, 2010New Option to Connect Patients and Clinics Underscores Medtronic's Ongoing Efforts to Improve Clinic Efficiency and Simplify Patient Follow-up
MINNEAPOLIS, May 10, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) announced today that it now offers the new Medtronic M-Link(TM) cellular accessory, which provides cardiac device patients...
-
May 6, 2010RestoreSensor Neurostimulator Designed to Optimize Pain Relief for Patients Regardless of Body Position
MINNEAPOLIS, May 06, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today announced the initiation of a prospective, multi-center, randomized U.S. clinical trial for the RestoreSensorTM...
-
Apr 29, 2010Acquisition Will Expand Access to Innovative Treatment Options for Structural Heart Disease
MINNEAPOLIS, Apr 29, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT), and ATS Medical, Inc. (NASDAQ:ATSI), today announced that the companies have signed a definitive agreement under which...
-
Apr 27, 2010First-To-Market Feature Allows Integration of Data from Multiple Vendors' 12-lead Management Systems
REDMOND, Wash., Apr 27, 2010 (BUSINESS WIRE) --Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), today announced the launch of Version 4.1 of its LIFENET System....
-
Apr 22, 2010
MINNEAPOLIS, Apr 22, 2010 (BUSINESS WIRE) --Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced today the U.S. Food and Drug Administration (FDA) has...
-
Apr 21, 2010Acquisition Expands Product Offering and Pipeline for Cardiovascular Interventions
MINNEAPOLIS, Apr 21, 2010 (BUSINESS WIRE) --Moving to expand its product offering,Medtronic, Inc. (NYSE: MDT), announced today that it has completed the acquisition of Invatec, a developer of...
-
Apr 21, 2010Now Indicated for Treatment of Peripheral Disease in the Iliac Arteries, Self-Expanding (SE) Device Redefines Deployment Accuracy for Precise Placement
MINNEAPOLIS, Apr 21, 2010 (BUSINESS WIRE) --Broadening the scope of innovation for cardiovascular interventions beyond the heart, Medtronic, Inc. (NYSE: MDT), announced today that it has received...
-
Apr 14, 2010
MINNEAPOLIS, Apr 14, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today announced it has named Caroline Stockdale as senior vice president of human resources effective April 30, 2010. In her...
-
Apr 9, 2010Hydrodebrider System Offers Innovative Treatment for Chronic Sinusitis
MINNEAPOLIS, Apr 09, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) announced today that the company was named a 2010 Medical Device Excellence Award (MDEA) winner for excellence in medical device...
-
Apr 8, 2010
MINNEAPOLIS, Apr 08, 2010 (BUSINESS WIRE) --Medtronic, Inc., (NYSE:MDT) received yesterday a Beacon Award from The Beacon Council, Miami-Dade County's official economic development organization,...
-
Apr 7, 2010Hydrodebrider System Offers Innovative Treatment for Chronic Sinusitis that Affects Nearly 30 Million US Adults1
MINNEAPOLIS, Apr 07, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) announced today the launch of a new Frontal Handpiece for its Hydrodebrider(TM) System, manufactured by the company's Ear Nose and...